Key | % Net Assets |
---|---|
Exxon Mobil | 5.6% |
Microsoft | 3.5% |
Johnson & Johnson | 3.2% |
Pfizer | 2.5% |
Other | 85.2% |
Name | % Net Assets |
---|---|
Exxon Mobil | 5.6% |
Microsoft | 3.5% |
Johnson & Johnson | 3.2% |
Pfizer | 2.5% |
Intel | 2.3% |
General Electric | 2.3% |
ConocoPhillips | 2.1% |
Monsanto | 2.0% |
Lilly (Eli) | 2.0% |
Medtronic | 1.9% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 1,217.00p |
Currency | GBP |
Change | 6.00p |
% | 0.50% |
YTD change | 259.40p |
YTD % | 27.09% |
Fund Inception | 15/10/1984 |
---|---|
Fund Manager | Erik Rubingh |
TER | 1.95 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.04 |
You are here: research